Main variables	Main activity, secondary one or a tool necessary for production	Total
Companies that carry out R&D in Biotechnology	Total	304.0
Companies that carry out R&D in Biotechnology	Main	187.0
Companies that carry out R&D in Biotechnology	Secondary dwellings	295.0
Companies that carry out R&D in Biotechnology	Tool	786.0
%Companies according to biotechnology used: Genetic code	Total	56.9
%Companies according to biotechnology used: Genetic code	Main	35.0
%Companies according to biotechnology used: Genetic code	Secondary dwellings	23.1
%Companies according to biotechnology used: Genetic code	Tool	39.0
%Companies according to biotechnology used: Functional units	Total	55.7
%Companies according to biotechnology used: Functional units	Main	29.1
%Companies according to biotechnology used: Functional units	Secondary dwellings	16.5
%Companies according to biotechnology used: Functional units	Tool	34.7
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Total	49.7
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Main	28.8
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Secondary dwellings	20.4
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Tool	33.8
%Companies according to biotechnology used: Bioprocesses	Total	41.6
%Companies according to biotechnology used: Bioprocesses	Main	37.9
%Companies according to biotechnology used: Bioprocesses	Secondary dwellings	46.8
%Companies according to biotechnology used: Bioprocesses	Tool	42.7
%Companies according to biotechnology used: Sub-cellular organisms	Total	17.8
%Companies according to biotechnology used: Sub-cellular organisms	Main	6.6
%Companies according to biotechnology used: Sub-cellular organisms	Secondary dwellings	3.9
%Companies according to biotechnology used: Sub-cellular organisms	Tool	10.0
%Companies according to biotechnology used: Bio-computing	Total	26.7
%Companies according to biotechnology used: Bio-computing	Main	14.1
%Companies according to biotechnology used: Bio-computing	Secondary dwellings	6.9
%Companies according to biotechnology used: Bio-computing	Tool	16.3
%Companies according to biotechnology used: Nanobiotechnology	Total	14.8
%Companies according to biotechnology used: Nanobiotechnology	Main	6.9
%Companies according to biotechnology used: Nanobiotechnology	Secondary dwellings	4.4
%Companies according to biotechnology used: Nanobiotechnology	Tool	9.0
%Companies according to biotechnology used: Other	Total	12.2
%Companies according to biotechnology used: Other	Main	23.2
%Companies according to biotechnology used: Other	Secondary dwellings	24.7
%Companies according to biotechnology used: Other	Tool	19.5
%Company by field(s) of ultimate application of biotechnology use: Human Health	Total	67.9
%Company by field(s) of ultimate application of biotechnology use: Human Health	Main	45.9
%Company by field(s) of ultimate application of biotechnology use: Human Health	Secondary dwellings	21.7
%Company by field(s) of ultimate application of biotechnology use: Human Health	Tool	45.4
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Total	24.7
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Main	22.7
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Secondary dwellings	14.7
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Tool	20.5
%Company by field(s) of ultimate application of biotechnology use: Food products	Total	29.8
%Company by field(s) of ultimate application of biotechnology use: Food products	Main	30.5
%Company by field(s) of ultimate application of biotechnology use: Food products	Secondary dwellings	46.9
%Company by field(s) of ultimate application of biotechnology use: Food products	Tool	36.4
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Total	21.5
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Main	17.7
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Secondary dwellings	23.4
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Tool	21.3
%Company by field(s) of ultimate application of biotechnology use: Environment	Total	17.1
%Company by field(s) of ultimate application of biotechnology use: Environment	Main	27.9
%Company by field(s) of ultimate application of biotechnology use: Environment	Secondary dwellings	15.4
%Company by field(s) of ultimate application of biotechnology use: Environment	Tool	19.1
%Company by field(s) of ultimate application of biotechnology use: Industry	Total	16.8
%Company by field(s) of ultimate application of biotechnology use: Industry	Main	17.3
%Company by field(s) of ultimate application of biotechnology use: Industry	Secondary dwellings	9.4
%Company by field(s) of ultimate application of biotechnology use: Industry	Tool	14.1
Personnel in R&D in biotechnology (no. of persons)	Total	4,037.0
Personnel in R&D in biotechnology (no. of persons)	Main	1,386.0
Personnel in R&D in biotechnology (no. of persons)	Secondary dwellings	1,542.0
Personnel in R&D in biotechnology (no. of persons)	Tool	6,965.0
Personnel in R&D in biotechnology (no. of persons): Researchers	Total	2,334.0
Personnel in R&D in biotechnology (no. of persons): Researchers	Main	832.0
Personnel in R&D in biotechnology (no. of persons): Researchers	Secondary dwellings	765.0
Personnel in R&D in biotechnology (no. of persons): Researchers	Tool	3,931.0
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Total	1,703.0
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Main	554.0
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Secondary dwellings	777.0
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Tool	3,034.0
Personnel in R&D in biotechnology (no. of persons): women	Total	2,419.0
Personnel in R&D in biotechnology (no. of persons): women	Main	745.0
Personnel in R&D in biotechnology (no. of persons): women	Secondary dwellings	755.0
Personnel in R&D in biotechnology (no. of persons): women	Tool	3,919.0
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Total	1,295.0
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Main	448.0
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Secondary dwellings	370.0
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Tool	2,113.0
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Total	1,124.0
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Main	297.0
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Secondary dwellings	385.0
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Tool	1,806.0
Personnel in R&D in biotechnology (FTE)	Total	3,502.0
Personnel in R&D in biotechnology (FTE)	Main	880.2
Personnel in R&D in biotechnology (FTE)	Secondary dwellings	950.1
Personnel in R&D in biotechnology (FTE)	Tool	5,332.3
Personnel in R&D in biotechnology (FTE): Researchers	Total	2,023.9
Personnel in R&D in biotechnology (FTE): Researchers	Main	548.8
Personnel in R&D in biotechnology (FTE): Researchers	Secondary dwellings	508.7
Personnel in R&D in biotechnology (FTE): Researchers	Tool	3,081.4
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Total	1,478.1
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Main	331.5
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Secondary dwellings	441.4
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Tool	2,251.0
Personnel in R&D in biotechnology (FTE): women	Total	2,111.6
Personnel in R&D in biotechnology (FTE): women	Main	501.1
Personnel in R&D in biotechnology (FTE): women	Secondary dwellings	493.0
Personnel in R&D in biotechnology (FTE): women	Tool	3,105.7
Personnel in R&D in biotechnology (FTE): (women) Researchers	Total	1,139.9
Personnel in R&D in biotechnology (FTE): (women) Researchers	Main	312.9
Personnel in R&D in biotechnology (FTE): (women) Researchers	Secondary dwellings	253.8
Personnel in R&D in biotechnology (FTE): (women) Researchers	Tool	1,706.6
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Total	971.7
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Main	188.2
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Secondary dwellings	239.2
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Tool	1,399.1
Internal expenditure on R&D (thousands of euros)	Total	350,072.0
Internal expenditure on R&D (thousands of euros)	Main	78,300.0
Internal expenditure on R&D (thousands of euros)	Secondary dwellings	59,884.0
Internal expenditure on R&D (thousands of euros)	Tool	488,256.0
1) By nature of the expense: Current expenses	Total	298,605.0
1) By nature of the expense: Current expenses	Main	51,463.0
1) By nature of the expense: Current expenses	Secondary dwellings	51,882.0
1) By nature of the expense: Current expenses	Tool	401,949.0
1.1) Remuneration to researchers	Total	95,484.0
1.1) Remuneration to researchers	Main	24,533.0
1.1) Remuneration to researchers	Secondary dwellings	22,817.0
1.1) Remuneration to researchers	Tool	142,834.0
1.2) Remuneration to technicians and assistants	Total	54,105.0
1.2) Remuneration to technicians and assistants	Main	10,023.0
1.2) Remuneration to technicians and assistants	Secondary dwellings	12,839.0
1.2) Remuneration to technicians and assistants	Tool	76,966.0
1.3) Other current expenses	Total	149,015.0
1.3) Other current expenses	Main	16,907.0
1.3) Other current expenses	Secondary dwellings	16,227.0
1.3) Other current expenses	Tool	182,149.0
2) By nature of the expense: Capital expenses	Total	51,468.0
2) By nature of the expense: Capital expenses	Main	26,837.0
2) By nature of the expense: Capital expenses	Secondary dwellings	8,002.0
2) By nature of the expense: Capital expenses	Tool	86,307.0
2.1) Land and buildings	Total	17,198.0
2.1) Land and buildings	Main	13,889.0
2.1) Land and buildings	Secondary dwellings	2,765.0
2.1) Land and buildings	Tool	33,852.0
2.2) Equipment and instruments	Total	31,345.0
2.2) Equipment and instruments	Main	12,521.0
2.2) Equipment and instruments	Secondary dwellings	5,082.0
2.2) Equipment and instruments	Tool	48,948.0
2.3) Acquisition of specific R+D software	Total	2,925.0
2.3) Acquisition of specific R+D software	Main	427.0
2.3) Acquisition of specific R+D software	Secondary dwellings	155.0
2.3) Acquisition of specific R+D software	Tool	3,507.0
1) By origin of the funds: National funds	Total	308,700.0
1) By origin of the funds: National funds	Main	75,453.0
1) By origin of the funds: National funds	Secondary dwellings	59,346.0
1) By origin of the funds: National funds	Tool	443,500.0
1.1) Own funds	Total	220,904.0
1.1) Own funds	Main	42,434.0
1.1) Own funds	Secondary dwellings	42,164.0
1.1) Own funds	Tool	305,502.0
1.2) From companies	Total	15,453.0
1.2) From companies	Main	3,287.0
1.2) From companies	Secondary dwellings	4,927.0
1.2) From companies	Tool	23,667.0
1.3) Public Administration funds	Total	70,496.0
1.3) Public Administration funds	Main	29,549.0
1.3) Public Administration funds	Secondary dwellings	12,151.0
1.3) Public Administration funds	Tool	112,196.0
1.4) From Universities	Total	115.0
1.4) From Universities	Main	112.0
1.4) From Universities	Secondary dwellings	87.0
1.4) From Universities	Tool	314.0
1.5) From non profit private institutions	Total	1,733.0
1.5) From non profit private institutions	Main	71.0
1.5) From non profit private institutions	Secondary dwellings	18.0
1.5) From non profit private institutions	Tool	1,822.0
1) By origin of the funds: Foreign funds	Total	41,372.0
1) By origin of the funds: Foreign funds	Main	2,846.0
1) By origin of the funds: Foreign funds	Secondary dwellings	538.0
1) By origin of the funds: Foreign funds	Tool	44,756.0
2.1) From EU programmes	Total	4,761.0
2.1) From EU programmes	Main	1,362.0
2.1) From EU programmes	Secondary dwellings	378.0
2.1) From EU programmes	Tool	6,501.0
2.2) Other foreign funds	Total	36,611.0
2.2) Other foreign funds	Main	1,485.0
2.2) Other foreign funds	Secondary dwellings	160.0
2.2) Other foreign funds	Tool	38,256.0
Purchase of R&D services in biotechnology (thousands of euros)	Total	48,888.0
Purchase of R&D services in biotechnology (thousands of euros)	Main	5,780.0
Purchase of R&D services in biotechnology (thousands of euros)	Secondary dwellings	6,931.0
Purchase of R&D services in biotechnology (thousands of euros)	Tool	61,599.0
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Total	38,820.0
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Main	5,535.0
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Secondary dwellings	5,682.0
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Tool	50,036.0
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Total	10,068.0
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Main	245.0
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Secondary dwellings	1,249.0
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Tool	11,562.0
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Total	51.1
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Main	47.4
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Secondary dwellings	40.2
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Tool	46.1
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Total	11.0
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Main	12.2
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Secondary dwellings	12.2
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Tool	11.7
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Total	18.3
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Main	18.7
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Secondary dwellings	14.3
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Tool	16.9
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Total	23.8
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Main	10.8
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Secondary dwellings	18.3
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Tool	18.7
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Total	25.3
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Main	17.9
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Secondary dwellings	16.6
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Tool	20.3
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Total	26.7
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Main	16.5
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Secondary dwellings	15.9
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Tool	20.2
%Companies that consider the following obstacles as very important considering biotechnology development : Public acceptance / awareness	Total	19.1
%Companies that consider the following obstacles as very important considering biotechnology development : Public acceptance / awareness	Main	19.5
%Companies that consider the following obstacles as very important considering biotechnology development : Public acceptance / awareness	Secondary dwellings	18.7
%Companies that consider the following obstacles as very important considering biotechnology development : Public acceptance / awareness	Tool	19.0
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Total	34.5
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Main	25.4
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Secondary dwellings	26.0
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Tool	29.1
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Total	53.2
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Main	46.4
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Secondary dwellings	37.0
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Tool	45.5
%Companies that consider the following obstacles as very important considering biotechnology development : Patent rights belonging to third parties	Total	17.9
%Companies that consider the following obstacles as very important considering biotechnology development : Patent rights belonging to third parties	Main	18.7
%Companies that consider the following obstacles as very important considering biotechnology development : Patent rights belonging to third parties	Secondary dwellings	9.3
%Companies that consider the following obstacles as very important considering biotechnology development : Patent rights belonging to third parties	Tool	14.8
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Total	13.2
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Main	13.4
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Secondary dwellings	9.0
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Tool	11.7
% Companies that have requested biotechnology patents	Total	26.9
% Companies that have requested biotechnology patents	Main	10.0
% Companies that have requested biotechnology patents	Secondary dwellings	8.7
% Companies that have requested biotechnology patents	Tool	16.1
Number of patents requested	Total	187.0
Number of patents requested	Main	71.0
Number of patents requested	Secondary dwellings	48.0
Number of patents requested	Tool	306.0
% Companies with income of an international origin related to biotechnological activities	Total	25.0
% Companies with income of an international origin related to biotechnological activities	Main	16.9
% Companies with income of an international origin related to biotechnological activities	Secondary dwellings	6.6
% Companies with income of an international origin related to biotechnological activities	Tool	16.1
% Turnover representing income of an international origin related to biotechnological activities	Total	6.90
% Turnover representing income of an international origin related to biotechnological activities	Main	1.50
% Turnover representing income of an international origin related to biotechnological activities	Secondary dwellings	1.20
% Turnover representing income of an international origin related to biotechnological activities	Tool	2.80
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Total	43.50
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Main	64.70
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Secondary dwellings	44.40
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Tool	46.80
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Total	56.60
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Main	35.30
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Secondary dwellings	55.60
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Tool	53.20
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Total	94.20
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Main	97.50
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Secondary dwellings	99.70
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Tool	95.80
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Total	0.20
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Main	0.70
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Secondary dwellings	.
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Tool	0.20
% Income of an international origin related with activities according to the classification: Operating source abroad	Total	0.40
% Income of an international origin related with activities according to the classification: Operating source abroad	Main	1.80
% Income of an international origin related with activities according to the classification: Operating source abroad	Secondary dwellings	0.20
% Income of an international origin related with activities according to the classification: Operating source abroad	Tool	0.50
% Income of an international origin related with activities according to the classification: Other	Total	5.30
% Income of an international origin related with activities according to the classification: Other	Main	.
% Income of an international origin related with activities according to the classification: Other	Secondary dwellings	0.10
% Income of an international origin related with activities according to the classification: Other	Tool	3.50